New obesity pharmacotherapies, including GLP-1 receptor agonists and combinations of entero-pancreatic hormones, show promise in achieving significant weight loss, potentially rivaling bariatric surgery’s effectiveness.
Breakthrough obesity treatments on the horizon, rivaling surgery’s success
- Post author:
- Post published:February 4, 2024
- Post category:uncategorized